USPTO serial 99336821
DOCTOR CANNA
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- DUONG, ANGELA GAW
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: 25 Aug 2026
Need help with DOCTOR CANNA?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
Office Action issues
The USPTO examiner found no conflicting marks but refused registration under federal controlled substance and drug laws, and requested additional information about your services.
Owner
EndoPure Life Sciences LLC
North Bergen, NJ, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research and development services relating to medicines; Research and development of medicines | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| May 25, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| May 25, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| May 25, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| May 18, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Dec 30, 2025 | DOCK | ASSIGNED TO EXAMINER |
| Dec 30, 2025 | DOCK | ASSIGNED TO EXAMINER |
| Dec 29, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Aug 14, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Aug 14, 2025 | NWAP | NEW APPLICATION ENTERED |